Page last updated: 2024-10-28

hydroxychloroquine and Cystic Fibrosis of Pancreas

hydroxychloroquine has been researched along with Cystic Fibrosis of Pancreas in 4 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Morlacchi, LC1
Rossetti, V1
Gigli, L1
Amati, F1
Rosso, L1
Aliberti, S1
Nosotti, M1
Blasi, F1
Giglia, M1
Beci, G1
Rosselli Del Turco, E1
Guardigni, V1
Amedeo, A1
Cucchetto, G1
Verucchi, G1
Cipolli, M1
Calza, L1
Viale, P1
Rayess, N1
Patel, VR1
Sagransky, DM1
Greenwald, RA1
Gorvoy, JD1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Safety and Immunogenicity of the SARS-CoV2 Vaccine in Solid Organ Transplantation (Lung and / or Liver) Adult Recipients[NCT05116748]200 participants (Anticipated)Observational2021-10-01Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

4 other studies available for hydroxychloroquine and Cystic Fibrosis of Pancreas

ArticleYear
COVID-19 in lung transplant recipients: A case series from Milan, Italy.
    Transplant infectious disease : an official journal of the Transplantation Society, 2020, Volume: 22, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Anticoagulants; Blood Gas Analysis; COVID-19; COVID-19 Drug Treatment;

2020
SARS-CoV-2 related pneumonia in an adult with cystic fibrosis: natural favourable clinical course or effective therapy?
    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2020, Dec-23, Volume: 90, Issue:4

    Topics: Adult; Antibodies, Monoclonal, Humanized; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Cysti

2020
Bilateral Severe Decreased Vision With Normal Examination Findings.
    JAMA ophthalmology, 2018, 10-01, Volume: 136, Issue:10

    Topics: Adult; Antibiotics, Antineoplastic; Antirheumatic Agents; Autoimmune Diseases; Cataract; Cystic Fibr

2018
Seropositive rheumatoid arthritis in a patient with cystic fibrosis.
    American journal of diseases of children (1960), 1980, Volume: 134, Issue:3

    Topics: Adolescent; Arthritis, Juvenile; Cystic Fibrosis; Female; Gold Sodium Thiomalate; Humans; Hydroxychl

1980